The Effects of Visior on Ocular Hemodynamics
1 other identifier
interventional
35
1 country
1
Brief Summary
To determine the relationship between the affects of viewing commercially available content through the VISIOR video goggles and ocular blood flow in glaucoma patients and healthy subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2016
CompletedFirst Posted
Study publicly available on registry
November 9, 2016
CompletedStudy Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedAugust 14, 2018
August 1, 2018
5 months
November 1, 2016
August 11, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
retinal capillary blood flow
retinal capillary blood flow in arbitrary units
1 day
Study Arms (2)
Glaucoma patients
EXPERIMENTALTo view commercially available content through the VISIOR video goggles for thirty minutes
Healthy subjects
EXPERIMENTALTo view commercially available content through the VISIOR video goggles for thirty minutes.
Interventions
View commercially available content through the VISIOR video goggles continuously for thirty minutes.
Eligibility Criteria
You may qualify if:
- Patients with open-angle glaucoma 30 years or older, free from other ophthalmic disease, free from diabetes, beta agonists and uncontrolled blood pressure.
You may not qualify if:
- Women who are pregnant or lactating or who plan to become pregnant (self reporting); smoker during last ten years (self reporting); systemic diseases that may interfere with blood flow measurements or wearing the goggles.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Visior Technologies Ltd.lead
- Indiana University School of Medicinecollaborator
Study Sites (1)
Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana School of Medicine
Indianapolis, Indiana, 46202, United States
Related Publications (1)
Siesky B, Harris A, Gross J, Sechrist E, Camp D, Cardenas A, Patel P, Hasnain F, Kawiecki R, Shah A, Verticchio Vercellin AC. Effects of image brightness and contrast dynamic altering stimuli (DAS) when viewing video content on ocular blood flow. Br J Ophthalmol. 2019 Oct;103(10):1511-1517. doi: 10.1136/bjophthalmol-2018-312561. Epub 2019 Jan 2.
PMID: 30602450DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alon Harris, PhD
Indiana University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 2016
First Posted
November 9, 2016
Study Start
January 1, 2017
Primary Completion
June 1, 2017
Study Completion
June 1, 2017
Last Updated
August 14, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share